About Index Trending news
Analyze
Pricing

Pharmaceuticals

400+ Companies
Companies

Established hub

424
Funding and Acquisitions

2016 Q4

38 + 9
Curators of Pharmaceuticals
PE Hub

Prometic to raise additional $25 mln from Thomvest vehicle

Funding Stock markets
TechMoran

Merck Accelerator announces 3 startups to join its program in Nairobi

Xconomy

SutroVax Lands $64M From Roche, Others to Back Vaccine Studies

Health Funding
$6,000,000 Grant
Vaxess

Vaxess Receives $6 Million from Gates Foundation to Develop Microneedle Patch Vaccines

PE Hub

PBM Capital sells majority stake in Breas to Fosun

Manufacturing Funding
$25,000,000 Venture capital (Series A)
biocentury

Dauntless adds $25M to series A round

$40,000,000 Undisclosed
PE Hub

Aerio Pharmaceuticals takes in about $40 mln

Funding Messaging
Xconomy

WARF, Cellectar Expand Licensing Agreement For Blood Cancer Drug

PE Hub

Germany's Stada attracts interest from Fosun Pharma, say sources: Reuters

Strategy Messaging
€2,000,000 Venture capital
Independent.ie

Venture capitalist Fielding helps pharma company Solvotrin raise €2m

PE Hub

OPC to buy VC-backed Neurovance

Health Funding
PE Hub

SFW to exit Essen BioScience for $320 mln

Science Apps & Services
Venture capital (Series C)
startupticker

Apidel SA closes third financing round Startupticker.ch | The Swiss Startup News channel

$20,180,000 Venture capital
MassDevice , sec

CardioFocus raises $20m, looking for $12m more

$38,000,000 Venture capital (Series A)
businesswire

Arrakis Therapeutics Announces $38 Million Series A Financing to Target RNA with Small-Molecule Medicines and Names Michael Gilman Chairman and CEO

Post-IPO debt
biospace

BioDelivery Secures Debt Financing With CRG

$74,000,000 Venture capital (Series B)
PE Hub

PMV Pharma bags $74 mln Series B

Data leaks Funding
PE Hub

Fusion Pharmaceuticals racks up $25 mln Series A

Messaging Funding
$25,000,000 Venture capital (Series A)
businesswire

Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments

Xconomy

Aiming At P53, Cancer's Hard Target, PMV Pharma Raises $74M